0001209191-20-044542.txt : 20200803 0001209191-20-044542.hdr.sgml : 20200803 20200803175444 ACCESSION NUMBER: 0001209191-20-044542 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200730 FILED AS OF DATE: 20200803 DATE AS OF CHANGE: 20200803 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MORTON DAVID H JR CENTRAL INDEX KEY: 0001476070 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38698 FILM NUMBER: 201070422 MAIL ADDRESS: STREET 1: SEAGATE TECHNOLOGY STREET 2: 920 DISC DRIVE CITY: SCOTTS VALLEY STATE: CA ZIP: 95066 FORMER NAME: FORMER CONFORMED NAME: MORTON DAVID H DATE OF NAME CHANGE: 20091103 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Anaplan, Inc. CENTRAL INDEX KEY: 0001540755 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372] IRS NUMBER: 270897861 STATE OF INCORPORATION: DE FISCAL YEAR END: 0131 BUSINESS ADDRESS: STREET 1: 50 HAWTHORNE STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94105 BUSINESS PHONE: 415-742-8199 MAIL ADDRESS: STREET 1: 50 HAWTHORNE STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94105 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-07-30 0 0001540755 Anaplan, Inc. PLAN 0001476070 MORTON DAVID H JR 50 HAWTHORNE STREET SAN FRANCISCO CA 94105 0 1 0 0 Chief Financial Officer Common Stock 2020-07-30 4 S 0 25099 45.0467 D 30620 D Common Stock 2020-07-30 4 M 0 4901 11.86 A 35521 D Common Stock 2020-07-30 4 S 0 4901 45.0692 D 30620 D Stock Option (right to buy) 11.86 2020-07-30 4 M 0 4901 0.00 D 2028-09-13 Common Stock 4901 144064 D This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $45 to $45.21, inclusive. The Reporting Person undertakes to provide to the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4. The Form 4 filed by the Reporting Person on June 12, 2020, inadvertently overstated the number of securities beneficially owned by the Reporting Person by 282 shares of common stock. The total reported in Column 5 corrects for that overstatement. This exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $45 to $45.18, inclusive. The Reporting Person undertakes to provide to the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4. 25% of the stock option vested on September 10, 2019, with the remainder exercisable in 36 equal monthly installments thereafter provided that the Reporting Person remains in continuous service on each vesting date; the option may also be exercised early subject to Issuer's right of repurchase. /s/ Gary Spiegel, Attorney-in-Fact 2020-08-03